We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNTH icon
76
Lantheus
LNTH
$6.53B
$15.2M 0.08%
+184,000
New +$11.9M
AJRD
77
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$15.2M 0.08%
+270,000
New +$15.1M
AAC
78
DELISTED
Ares Acquisition Corporation
AAC
$14.7M 0.08%
1,425,000
AVTR icon
79
Avantor
AVTR
$9.78B
$14.4M 0.08%
681,418
+152,954
+29% +$3.49M
FWAC
80
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$13.9M 0.08%
1,360,040
TCVA
81
DELISTED
TCV Acquisition Corp. Class A Ordinary Shares
TCVA
$12.4M 0.07%
1,211,459
ISEE
82
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$11.8M 0.06%
484,799
-977,201
-67% -$21.4M
BRMK
83
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
$11.5M 0.06%
2,437,995
-2,412,005
-50% -$10.7M
YTPG
84
DELISTED
TPG Pace Beneficial II Corp.
YTPG
$11.1M 0.06%
1,116,833
COGT icon
85
Cogent Biosciences
COGT
$6.37B
$10.6M 0.06%
983,452
+898,313
+1,055% +$11.5M
BHVN icon
86
Biohaven
BHVN
$2.09B
$10.2M 0.06%
750,000
-250,000
-25% -$3.98M
SCRM
87
DELISTED
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
$10.2M 0.06%
1,000,000
CVII
88
DELISTED
Churchill Capital Corp VII Class A Common Stock
CVII
$10.1M 0.06%
1,000,000
CCVI
89
DELISTED
Churchill Capital Corp VI
CCVI
$10.1M 0.06%
997,767
TVRD
90
Tvardi Therapeutics
TVRD
$24.8M
$9.8M 0.05%
55,427
-2,190
-4% -$733K
NETC
91
DELISTED
Nabors Energy Transition Corp.
NETC
$9.45M 0.05%
900,000
RIO icon
92
Rio Tinto
RIO
$171B
$9.43M 0.05%
+137,500
New +$9.98M
PSPC
93
DELISTED
Post Holdings Partnering Corporation
PSPC
$8.58M 0.05%
848,184
KCGI
94
DELISTED
Kensington Capital Acquisition Corp. V
KCGI
$8.08M 0.04%
775,200
APGB
95
DELISTED
Apollo Strategic Growth Capital II
APGB
$7.69M 0.04%
750,000
PANA
96
DELISTED
Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
$7.65M 0.04%
750,000
ARYE
97
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$7.62M 0.04%
745,000
CORS
98
DELISTED
Corsair Partnering Corporation
CORS
$7.18M 0.04%
700,000
KVSA
99
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
$7.1M 0.04%
700,000
ALVO icon
100
Alvotech
ALVO
$1.5B
$6.45M 0.04%
500,000

Similar funds

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.